Chronic metoclopramide therapy for diabetic gastroparesisLATA, Paul F; PIGARELLI, Denise L.The Annals of pharmacotherapy. 2003, Vol 37, Num 1, pp 122-126, issn 1060-0280, 5 p.Article

Ghrelin gastrokinetic action in patients with neurogenic gastroparesisBINN, M; ALBERT, C; GOUGEON, A et al.Peptides (New York, NY. 1980). 2006, Vol 27, Num 7, pp 1603-1606, issn 0196-9781, 4 p.Article

Predictive Factors for Clinical Improvement with Enterra Gastric Electric Stimulation Treatment for Refractory GastroparesisMARANKI, Jennifer L; LYTES, Vanessa; MEILAHN, John E et al.Digestive diseases and sciences. 2008, Vol 53, Num 8, pp 2072-2078, issn 0163-2116, 7 p.Article

Multicenter, Double-Blind, Placebo-Controlled Crossover Study to Assess the Acute Prokinetic Efficacy of Nizatidine-Controlled Release (150 and 300 mg) in Patients With Gastroesophageal Reflux DiseaseMCCALLUM, Richard W; ZARLING, Edwin J; GOETSCH, Allen C et al.The American journal of the medical sciences (Print). 2010, Vol 340, Num 4, pp 259-263, issn 0002-9629, 5 p.Article

Motilides: A long and winding road. Lessons from mitemcinal (GM-611) on diabetic gastroparesisTAKANASHI, Hisanori; CVNSHI, Osamu.Regulatory peptides. 2009, Vol 155, Num 1-3, pp 18-23, issn 0167-0115, 6 p.Conference Paper

Measurement of gastric emptying by ¹³C-octanoic acid breath test versus scintigraphy in diabeticsZAHN, A; LANGHANS, C.-D; HOFFNER, S et al.Zeitschrift für Gastroenterologie. 2003, Vol 41, Num 5, pp 383-390, issn 0044-2771, 8 p.Article

Aryl sulphonyl amides as potent agonists of the growth hormone secretagogue (ghrelin) receptorWITHERINGTON, Jason; ABBERLEY, Lee; TAKLE, Andrew K et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 3, pp 684-687, issn 0960-894X, 4 p.Article